Vaccine requirements for sustained cellular immunity to an intracellular parasitic infection

Nature Medicine

Volumn 4, Issue 12, 1998, Pages 1409-1415

  Gurunathan, Sanjay ^a   Prussin, Calman ^b   Sacks, David L ^b   Seder, Robert A ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 12; LEISHMANIA VACCINE; PARASITE ANTIGEN; PLASMID DNA;

ANIMAL CELL; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG DESIGN; LEISHMANIA MAJOR; LEISHMANIASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; VACCINATION; VACCINE PRODUCTION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIGENS, PROTOZOAN; IMMUNITY, CELLULAR; INTERFERON TYPE II; INTERLEUKIN-12; LEISHMANIA MAJOR; LEISHMANIASIS, CUTANEOUS; MICE; MICE, INBRED BALB C; PROTOZOAN PROTEINS; PROTOZOAN VACCINES; RECOMBINANT PROTEINS; VACCINES, DNA;

ANIMALIA; BACTERIA (MICROORGANISMS); LEISHMANIA MAJOR; MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS;

EID: 0031757985     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/4000     Document Type: Article

References (32)

1. Reiner, S.L. & Locksley, R.M. The regulation of immunity to Leishmania major. Annu. Rev. Immuol. 13, 151-177 (1995).
2. Heinzel, F.P., Schoenhaut, D.S., Rerko, R.M., Rosser, L.E. & Gately, M.K. Recombinant interleukin 12 cures mice infected with Leishmania major. J. Exp. Med. 177, 1505-1509 (1993).
3. Sypek, J.P. et al. Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response. J. Exp. Med. 177, 1797-1802 (1993).
4. Scharton-Kersten, T., Alfonso, L.C., Wysocka, M., Trinchieri, G. & Scott, P. IL-12 is required for NK cell activation and subsequent Th1 cell development in experimental leishmaniasis. J. Immunol. 154, 5320-5330 (1995).
5. Locksley, R.M., Reiner, S.L., Hatam, F., Littman, D.R. & Killeen, N. 1993. Helper T cells without CD4: control of leishmaniasis in CD4-deficient mice. Science 261, 1448-1451 (1993).
6. Launois, P., Swihart, K.G., Milon, G. & Louis, J.A. Early production of IL-4 in susceptible mice infected with Leishmania major rapidly induces IL-12 unresponsiveness. J. Immunol. 158, 3317-3324 (1997).
7. Julia, V., Rassoulzadegan, M. & Glaichenhaus, N. Resistance to Leishmania major induced by tolerance to a single antigen. Science 274, 421-423 (1996).
8. + T cells instructs Th2 development and susceptibility to Leishmania major in BALB/c mice. Immunity 6, 541-549 (1997).
9. Afonso, L.C. et al. The adjuvant effect of interleukin-12 in a vaccine against Leishmania major. Science 263, 235-237 (1994).
10. Mougneau, E. et al. Expression cloning of a protective Leishmania antigen. Science 268, 563-566 (1995).
11. Gurunathan, S. et al. Vaccination with DNA encoding the immunodominant LACK parasite antigen confers protective immunity to mice infected with Leishmania major. J. Exp. Med. 186, 1137-1147 (1997).
12. Jankovic, D. et al. Adsorption to aluminum hydroxide promotes the activity of IL-12 as an adjuvant for antibody as well as type 1 antibody responses to HIV-1 gp120. J. Immunol. 159, 2409-2417 (1997).
13. Campbell, K. A. et al. CD40 ligand is required for protective cell-mediated immunity to Leishmania major. Immunity 14, 283-289 (1996).
14. Ma, X. et al. The IL-12 p40 gene promoter is primed by IFN-γ in monocytic cells. J. Exp. Med. 183,-174 (1996).
15. + T-helper and a T-killer cell. Nature 393, 474-477 (1998).
16. Bennett, S.R.M. et al. Help for cytotoxic T-cell responses is mediated by CD40 signalling. Nature 393, 478-480 (1998).
17. Schoenberger, S.P., Toes, R.E.M., van der Voort, E.I.H., Offringa, R. & Melief, C.J.M. T-cell help for cytotoxic T cells is mediated by CD40-CD40L interactions. Nature 393, 480-483 (1998).
18. Wolff, J. A., Ludtke, J.J., Acsadi, G., Williams, P. & Jani, A. Long-term persistence of plasmid DNA and foreign gene expression in mouse muscle. Hum. Mol. Genet. 1, 363-369 (1992).
19. Klinman, D.M., Yi, A.K., Beaucage, S.L., Conover, J. & Krieg, A.M. CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon γ. Proc. Natl. Acad. Sci. USA 93, 2879-2883 (1996).
20. Sato, Y. et al. Immunostimulatory DNA sequences necessary for effective intra-dermal gene immunization. Science 273, 352-354 (1996).
21. Zimmermann, S. et al. CpG oligodeoxynucleotides trigger protective and curative Th1 responses in lethal murine leishmaniasis. J. Immunol. 160; 3627-3630 (1998).
22. Seder, R.A., Kelsall, B.L. & Jankovics, D. Differential roles of IL-12 in maintenance of immune responses in infectious vs. autoimmune disease. J. Immunol. 157, 2745-2748 (1996).
23. + T cells, interleukin-4 production is cytokine-autonomous, whereas interferon γ production is cytokine dependent. Proc. Natl. Acad. Sci. USA 94, 3189-3194 (1997).
24. Murphy, E.E. et al. B7 and interleukin 12 cooperate for proliferation and interferon-γ production by mouse T helper clones that are unresponsive to B7 costimulation. J. Exp. Med. 180, 223-231 (1994).
25. Clerici, M. et al. Type 1/type 2 cytokine modulation to T-cell programed cell death as a model for human immunodeficiency virus pathogenesis. Proc. Natl. Acad. Sci. USA 91, 11811-11815 (1994).
26. Marth, T., Strober, W. & Kelsall, B.L. High dose oral tolerance in ovalbumin TCR-transgenic mice. Systemic neutralization of IL-12 augments TGF-β secretion and T cell apoptosis. J. Immunol. 157, 2348-2357 (1996).
27. + T cells. Int. Immunol. 3, 587-597 (1991).
28. + T cells. Infect. Immunol. 61, 3730-3738 (1993).
29. + cytotoxic T cell responses. Eur. J. Immunol. 24, 2813-2817 (1994).
30. + T cells are inducers and targets of nitric oxide produced by parasitized macrophages. Eur. J. Immunol. 24, 746-752 (1994).
31. Conceicao-Silva, F., Hahne, M., Schröter M., Louis J. & Tschopp, J. The resolution of lesions induced by Leishmania major in mice requires a functional Fas (APO-1, CD95) pathway of cytotoxicity. Eur. J. Immunol. 28, 237-245 (1998).
32. Behr, M.A. & Small, P.M. Has BCG attenuated to impotence? Nature 389, 133-134 (1997).